Inactief instrument

Koers MATRX Pharmaceuticals S.A.

Aandelen

Duur

Periode

Stijl

MATRX Pharmaceuticals S A : SEC Investor Advisory Committee Discusses SPACs	16-03-21
An unknown buyer acquired 58% stake in MATRX Pharmaceuticals S.A. from Ajay Pal.	28-12-18
An unknown buyer acquired 65% stake in MATRX Pharmaceuticals S.A. from PRO SP. Z O.O.	25-06-18
PRO SP. Z O.O. acquired 65% stake in MATRX Pharmaceuticals S.A..	06-03-18
CoGyn Pharmaceuticals, Inc. completed the acquisition of MATRX Pharmaceuticals S.A. in a reverse merger transaction.	11-03-16

Managers	Titel	Leeftijd	Van
Ajay Pal CEO	Chief Executive Officer	-	08-06-18
Robert S. Cohen CEO	Chief Executive Officer	-	15-12-08
Charles M. Mixon DFI	Director of Finance/CFO	-	-

Besturend	Titel	Leeftijd	Van
Dominik Zbigniew Dymecki BRD	Director/Board Member	43	21-06-17
Edyta Jeleniewska BRD	Director/Board Member	53	21-06-17
Malgorzata Dymecka BRD	Director/Board Member	45	21-06-17

Sector